Sharepoint Solutions
PRODUCTS
-
Our experts implement proven, streamlined processes that maintain compliance, quality standards, and efficiency while also managing costs, schedules, and scope.
-
Our proprietary GlobalReady model covers the entire drug development journey from robust EARLY PHASE clinical foundations with ClinicReady to seamless multi-regional Late phase expansion. All managed by the one award-winning CRO, saving time and costs and delivering rigorous globally accepted data.
-
DECODE, the Digital Endpoint Collaboration for Outcomes Development, is Ametris’ pre-competitive collaboration framework designed to help address shared clinical measurement challenges across the life sciences industry. In regulatory contexts where evidence expectations are high, digital measures must be meaningful to patients, scientifically valid, operationally feasible, and aligned with regulatory expectations. By supporting the development and validation of fit-for-purpose, patient-centered digital measures, DECODE helps transform real-world data into validated clinical evidence across clinical research programs.
-
With 30+ years of experience in viral vector development and manufacturing, we bring unmatched expertise as your trusted CDMO for AAV. From plasmids to fill/finish and advanced analytics, we provide true end-to-end support, accelerating your path to the clinic and beyond.
-
Guide operators through dynamic workflows from equipment startup to maintenance.
WHITE PAPERS AND CASE STUDIES
-
A Solid Solution And Impeccable Service Wins Over This Client
In this case study, learn why Canada's oldest cheese company looked to Newterra for systems and support.
-
The Benefits Of End-To-End Formulation And Fill/Finish Of Biologics
Proper formulation development has a huge impact on whether a technology transfer to clinical phase fill/finish is successful. Review the challenges of transitioning a promising drug candidate.
-
Patient-Focused Data Capture For Cancer Research
In a field where innovation is constant and patient experience is pivotal, oncology demands eCOA solutions designed to balance scientific rigor with human realities.
-
The Patient Recruitment Shift: Navigating Disruption, Delivering Precision
Explore the four macro trends reshaping the recruitment space in 2025—each grounded in emerging data, technology, and behavior shifts.
-
How Sponsors Are Responding To FDA's RTCT Request For Information
Let's take a look at where continuous, real-time regulatory review can meaningfully speed drug development, and where it likely won't help much.
-
Cleanroom Recovery. Proven Results. Contamination Control Case Studies
Through this collection, review how a proven, automated solution can help facilities stay compliant, operational, and protected — whether in a crisis or during planned maintenance.
-
How A QMS Embeds Quality Into Cell Therapy Production
Discover how a digital manufacturing solution helped a cellular therapy leader eliminate cleanroom paper, align quality teams, and accelerate batch release times by nearly 50%.
-
Pioneering Cancer Research Meets Unparalleled Veeva Vault Integration
A biotech company revolutionizing cancer treatment faced delays due to a complex, error-prone document review process. Discover how integrating an innovative strategy transformed their workflow.
-
Navigating The Challenges Of Large, International Phase III Breast Cancer Trials
In the competitive landscape of breast cancer research, aligning biomarker testing, regulatory pathways, and regional operations from day one creates a path to faster enrollment and stronger outcomes.
-
Incorrect Clinical Trial Enrollment Is Preventable. A Tale Of Three Case Studies
See how three clinical trials used centralized eligibility review to accelerate enrollment, eliminate enrollment-based protocol deviations, and keep studies on track, even at a global scale.
-
How A Global Biosimilars Company Cut Manual Data Errors By 50%
Learn how a global biopharmaceutical leader halved transcription errors and integrated over 350 instruments to accelerate the development of high-quality, clinically proven biosimilars.
-
FDA Recommendations For Gene Therapy For PMDs
Explore insight into the strategies and FDA recommendations for executing gene therapy development programs, specifically for primary mitochondrial diseases (PMDs).
NEWS
-
Study To Determine Most Effective PFAS Treatments For High-Risk Homes3/2/2026
Research to fill key knowledge gaps on the effectiveness of household water treatment systems for PFAS and other fluorinated organic compounds is under way under the direction of Assistant Professor Dr. Riley Mulhern of the University of Colorado Boulder.
-
300,000 Litres Of Synthetic Petrol Produced – Minister-President Kretschmer Visits The Technical University Of Freiberg To Find Out More9/11/2026
Today (11 September 2026) Saxony’s Minister-President Michael Kretschmer visited the TU Bergakademie Freiberg to learn about the progress of the BMV-funded DeCarTrans collaborative project at a large-scale pilot plant for the production of a synthetic fuel with virtually no CO2 emissions.
-
Energy Department Slashes 47 Burdensome And Costly Regulations, Delivering First Milestone In America's Biggest Deregulatory Effort5/12/2025
The U.S. Department of Energy (DOE) today announced the first step in the Energy Department’s largest deregulatory effort in history, proposing the elimination or reduction of 47 regulations that are driving up costs and lowering quality of life for the American people.
-
DEQ Awards $75,000 To Two Idaho Wastewater Systems1/3/2025
The Idaho Department of Environmental Quality (DEQ) today awarded $75,000 to two wastewater systems to help facilities evaluate system deficiencies and determine necessary upgrades.
-
Huachen AI Parking Management Technology Holding Co., Ltd. Expands Smart City Ecosystem With Launch Of 4G Smart Energy Management And Green Power Arbitrage Initiative2/2/2026
Huachen AI Parking Management Technology Holding Co., Ltd. (NASDAQ: HCAI, “Huachen” or the “Company”), a China-based smart-parking and equipment-structural-parts provider in China, today announced the strategic expansion of its Smart City ecosystem with the launch of its 4G Smart Energy Management and Green Power Arbitrage Initiative.